Literature DB >> 23455595

Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

Valentina Gigliucci1, Grainne O'Dowd, Sheena Casey, Danielle Egan, Sinead Gibney, Andrew Harkin.   

Abstract

RATIONALE: Behavioural antidepressant-like effects of ketamine have been reported in the forced swimming test (FST). The mechanisms mediating such effects are unknown.
OBJECTIVES: As serotonin (5-HT) is an important transmitter mediating antidepressant responsiveness in the FST, the influence of 5-HT depletion on the antidepressant-like effect of ketamine was assessed.
METHODS: The effect of ketamine (25 mg/kg, i.p., 1 or 24 h prior to test) was assessed in the FST in naive rats or animals subjected to 5-HT depletion, repeated stress or following a combination of 5-HT depletion and stress. Endogenous 5-HT was depleted using the tryptophan hydroxylase inhibitor para-chlorophenylalanine (3 × 150 mg/kg, i.p.). Stress was induced by physical restraint (2 h/day for 10 days).
RESULTS: In naive rats, ketamine administered 24 or 1 h prior to test produced a characteristic antidepressant-like reduction in immobility time in the FST. Depletion of 5-HT blocked this reduction in immobility when ketamine was administered 24 h prior FST, indicative of 5-HT dependency. The increase in immobility provoked by repeated restraint stress (2 h/day for 10 days) was blocked by ketamine when administered 24 h prior to FST, but this effect dissipated when animals were subjected to 5-HT depletion.
CONCLUSIONS: These observations are consistent with a role for 5-HT in mediating sustained antidepressant activity of ketamine in the FST. Molecular and cellular changes induced by ketamine may produce a rapid adaptation of 5-HT transmission which underlies the antidepressant response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455595     DOI: 10.1007/s00213-013-3024-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  53 in total

Review 1.  Ketamine as a novel antidepressant: from synapse to behavior.

Authors:  J W Murrough
Journal:  Clin Pharmacol Ther       Date:  2011-12-28       Impact factor: 6.875

Review 2.  Role of the serotonergic system in the forced swimming test.

Authors:  F Borsini
Journal:  Neurosci Biobehav Rev       Date:  1995       Impact factor: 8.989

3.  Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine.

Authors:  Mercè Amargós-Bosch; Xavier López-Gil; Francesc Artigas; Albert Adell
Journal:  Int J Neuropsychopharmacol       Date:  2005-08-15       Impact factor: 5.176

4.  Ketamine inhibits serotonin uptake in vivo.

Authors:  L L Martin; R L Bouchal; D J Smith
Journal:  Neuropharmacology       Date:  1982-02       Impact factor: 5.250

5.  Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.

Authors:  Sarah Durkin; Alison Prendergast; Andrew Harkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-09-13       Impact factor: 5.067

6.  Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.

Authors:  R Bernard; I A Kerman; R C Thompson; E G Jones; W E Bunney; J D Barchas; A F Schatzberg; R M Myers; H Akil; S J Watson
Journal:  Mol Psychiatry       Date:  2010-04-13       Impact factor: 15.992

7.  A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.

Authors:  Valentina Gigliucci; Kathleen Niamh Buckley; John Nunan; Karen O'Shea; Andrew Harkin
Journal:  Pharmacol Biochem Behav       Date:  2009-11-26       Impact factor: 3.533

8.  Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.

Authors:  E Engin; D Treit; C T Dickson
Journal:  Neuroscience       Date:  2009-03-24       Impact factor: 3.590

Review 9.  In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice.

Authors:  J F Cryan; C Mombereau
Journal:  Mol Psychiatry       Date:  2004-04       Impact factor: 15.992

10.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

View more
  56 in total

1.  The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.

Authors:  Kenichi Fukumoto; Michihiko Iijima; Shigeyuki Chaki
Journal:  Neuropsychopharmacology       Date:  2015-08-06       Impact factor: 7.853

Review 2.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

3.  Context-Specific Tolerance and Pharmacological Changes in the Infralimbic Cortex-Nucleus Accumbens Shell Pathway Evoked by Ketamine.

Authors:  Gleice Kelli Silva-Cardoso; Manoel Jorge Nobre
Journal:  Neurochem Res       Date:  2021-03-30       Impact factor: 3.996

4.  Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.

Authors:  Kenichi Fukumoto; Michihiko Iijima; Shigeyuki Chaki
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

5.  Impact of impaired glucose metabolism on responses to a psychophysical stressor: modulation by ketamine.

Authors:  Brett Melanson; Thomas Lapointe; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2021-01-06       Impact factor: 4.530

6.  Pharmaco-electroencephalographic responses in the rat differ between active and inactive locomotor states.

Authors:  Ingeborg H Hansen; Claus Agerskov; Lars Arvastson; Jesper F Bastlund; Helge B D Sørensen; Kjartan F Herrik
Journal:  Eur J Neurosci       Date:  2019-04-01       Impact factor: 3.386

7.  Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats.

Authors:  Todd M Hillhouse; Joseph H Porter; S Stevens Negus
Journal:  Drug Dev Res       Date:  2014-10-15       Impact factor: 4.360

8.  Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic-Pituitary-Adrenal Axis Function and Activating BDNF Signaling Pathway.

Authors:  Xianpeng Zu; Mingjian Zhang; Wencai Li; Haisheng Xie; Zhang Lin; Niao Yang; Xinru Liu; Weidong Zhang
Journal:  Neurochem Res       Date:  2017-07-31       Impact factor: 3.996

Review 9.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

10.  NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine.

Authors:  Victor A D Holanda; Wilton B Santos; Laila Asth; Remo Guerrini; Girolamo Calo'; Chiara Ruzza; Elaine C Gavioli
Journal:  Psychopharmacology (Berl)       Date:  2018-08-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.